Product Description
Sunscreening Agent
Mechanisms of Action: UV Blocker
Novel Mechanism: No
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Bayer
Company Location: LEVERKUSEN 2M D-51368
Company CEO: Werner Baumann
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| SPF Assay | N/A |
Completed |
Other |
2015-12-03 |
2019-03-22 |
Treatments |
|
| SPF Assay | N/A |
Completed |
Other |
2015-11-30 |
2019-03-20 |
Treatments |
|
| NCT02779270 | N/A |
Completed |
Sunburn |
2015-09-27 |
2019-03-20 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|